Peroxiredoxin 2 (PRDX2), an antioxidant enzyme, is under-expressed in Down syndrome fetal brains

Cellular and Molecular Life Sciences

Volumn 60, Issue 7, 2003, Pages 1513-1523

  Sanchez Font M F ^a   Sebastia J ^b   Sanfeliu, C ^b   Cristofol R ^b   Marfany, G ^a   Gonzalez Duarte R ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Differential expression; Down syndrome; Oxidative stress; Peroxiredoxin; SOD1; Suppression subtractive hybridization

Indexed keywords

ANTIOXIDANT; PEROXIREDOXIN;

ANEUPLOIDY; APOPTOSIS; ARTICLE; BRAIN TISSUE; CELL VIABILITY; CHROMOSOMAL LOCALIZATION; DOWN SYNDROME; FETUS; FETUS DEVELOPMENT; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; MALE; MOLECULAR HYBRIDIZATION; NEUROBLASTOMA; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; RECEPTOR DOWN REGULATION; SUPPRESSION SUBTRACTIVE HYBRIDIZATION;

APOPTOSIS; CASPASE 3; CASPASES; CELL SURVIVAL; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 13; CLONING, MOLECULAR; DOWN SYNDROME; FETUS; HUMANS; KINETICS; NEUROBLASTOMA; OXIDATIVE STRESS; PEROXIDASES; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; SUPEROXIDE DISMUTASE; THIMEROSAL; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0041867880     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-003-3048-1     Document Type: Article

References (41)

1. Hassold T. and Jacobs P. (1984) Trisomy in man. Annu. Rev Genet. 18: 69-97
2. Epstein C. J. (1995) Epilogue: toward twenty-first century with Down Syndrome - a personal view of how far we have come and how far we can reasonably expect to go. Prog Clin. Biol. Res. 393: 241-246
3. Hattori M., Fujiyama A., Taylor T. D., Watanabe H., Yada T., Parks H. S. et al. (2000) The DNA sequence of human chromosome 21. Nature 405: 311-319
4. Iannello R. C., Crack P. J., Haan J. B. de, and Kola I. (1999) Oxidative stress and neuronal dysfunction in Down syndrome. J. Transm. Suppl. 157: 257-268
5. Finkel T. (1998) Oxygen radicals and signaling. Curr. Opin. Cell Biol. 10: 248-253
6. Matés J. M. (2000) Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology. Toxicology 153: 83-104
7. Chae H. Z., Kim L.-H., Kim K., and Rhe S. G. (1993) Cloning, sequencing, and mutation of thiol-specific antioxidant gene of Saccharomyces cerevisiae. J. Biol. Chem. 268: 16815-16821
8. Lim Y. S., Cha M. K., Kim H. K., Uhm T. B., Park J. W., Kim K. et al. (1993) Removals of hydrogen peroxide and hydroxyl radical by thiol-specific antioxidant protein as a possible role in vivo. Biochem Biophys. Res. Commun. 192: 273-280
9. Chae H. Z., Chung S. J. and Rhee S. G. (1994) Thioredoxin-dependent peroxide reductase from yeast. J. Biol. Chem. 269: 27670-27678
10. Chae H. Z., Robison K., Poole L. B., Church G., Storz G. and Rhee S. G. (1994) Cloning and sequencing of thiol-specific antioxidant from mammalian brain: alkyl hydroperoxide reductase and thiol-specific antioxidant define a large family of antioxidant enzymes. Proc. Natl. Acad. Sci. USA 91: 7017-7021
11. Chae H. Z., Uhm T. B. and Rhee S. G. (1994) Dimerization of thiol-specific antioxidant and the essential role of cysteine 47. Proc. Natl. Acad. Sci. USA 91: 7022-7026
12. Yim M. B., Chae H. Z., Rhee S. G., Chock P. B. and Stadtman E. R. (1994) On the protective mechanism of the thiol-specific antioxidant enzyme against the oxidative damage of biomacromolecules. J. Biol. Chem. 269: 1621-1626
13. Netto L. E. S., Chae H. Z., Kang S.-W., Rhee S. G. and Stadtman E. R. (1996) Removal of hydrogen peroxide by thiol-specific antioxidant enzyme (TSA) is involved with its antioxidant properties. J. Biol. Chem. 271: 15315-15321
14. Sarafian T. A., Rajper N., Grigorian B., Kim A. and Shau H. (1997) Cellular antioxidant properties of human natural killer enhancing factor B. Free Radic. Res. 26: 281-289
15. Pahl P., Berger R., Hart I., Chae H. Z., Rhee S. G. and Patterson D. (1995) Localization of TDPX1, a human homologue of the yeast thioredoxin-dependent peroxide reductase gene (TPX), to chromosome 13q12. Genomics 26: 602-606
16. Sarafian T. A., Verity M. A., Vinters H. V., Shih C. C.-Y., Shi L., Ji X. D. et al. (1999) Differential expression of peroxiredoxin subtypes in human brain cell types. J. Neurosci. Res. 56: 206-212
17. Chae H. Z., Kim H. J., Kang S. W. and Rhee S. G. (1999) Characterization of three isoforms of mammalian peroxiredoxin that reduce peroxides in the presence of thioredoxin. Diabetes Res. Clin. Pract. 45: 101-112
18. 2 activities. J. Biol. Chem 275: 28421-28427
19. Lim M. J., Chae H. Z., Rhee S. G., Yu D.-Y., Lee K.-K. and Yeom Y. I. (1998) The type II peroxiredoxin gene family of the mouse: molecular structure, expression and evolution. Gene 216: 197-205
20. Kang S. W., Chae H. Z., Seo M. S., Kim K., Baines I. C. and Rhee S. G. (1998) Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-α. J. Biol. Chem. 273: 6297-6302
21. Kim H., Lee T.-H., Park E. S., Suh J. M., Park S. J., Chung H. K. et al. (2000) Role of peroxideroxins in regulating intracellular hydrogen peroxide and hydrogen peroxide-induced apoptosis in thyroid cells. J. Biol. Chem. 275: 18266-18270
22. Zhang P., Liu B., Kang S. W., Se M. S., Rhee S. G. and Obeid L. M. (1997) Thioredoxin peroxidase is a novel inhibitor of apoptosis with a mechanism distinct from that of Bcl-2. J. Biol. Chem. 272: 30615-30618
23. Chomczynsky P. and Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-169
24. Macklis J. D. and Madison R. D. (1990) Progressive incorporation of propidium iodide in cultured neurons correlates with declining electrophysiological status: a fluorescence scale of membrane integrity. J. Neurosci. Methods 3: 43-46
25. Hansen M. B., Nielsen S. E. and Berg K. (1989) Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 119: 203-210
26. 2+ homeostasis in cultured cerebellar granule cell neurons is different for the γ and δ isomers. Toxicol. Appl. Pharmacol. 142: 31-39
27. Mizuguchi M. and Hayakawa T. (2001) Characteristics of adenovirus-related tetracycline-controllable expression system. Biochim. Biophys. Acta 1568: 21-29
28. Schmidt-Sidor J. D., Wisniewski K. E., Shepard T. H. and Sersen E. A. (1990) Brain growth in Down syndrome subjects 15 to 22 weeks of gestational age and birth to 60 months. Clin. Neuropathol. 9: 181-190
29. Gulesserian T., Engidawork E., Fountoulakis M. and Lubec G. (2001) Antioxidant proteins in fetal brain: superoxide dismutase-1 (SOD-1) protein is not overexpressed in fetal Down syndrome. J. Neural Transm. Suppl. 61: 71-84
30. Kim S. H., Fountoulakis M., Cairns N. and Lubec G. (2001) Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer's disease and Down syndrome. J. Neural Transm. Suppl. 61: 223-235
31. Busciglio J. and Yankner B. A. (1995) Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature 378: 776-779
32. Nagy Z. (1999) Mechanisms of neuronal death in Down's syndrome. J. Neural Transm. Suppl. 57: 233-247
33. Kim A. T., Sarafian T. A. and Shau H. (1997) Characterization of antioxidant properties of natural killer-enhancing factor-B and induction of its expression by hydrogen peroxide. Toxicol. Appl. Pharmacol. 147: 135-142
34. Shau H., Huang A. C. J., Faris M., Nazarian R., Vellis J. D. and Chen W. (1998) Thioredoxin peroxidase (natural killer enhancing factor) regulation of activator protein-1 function in endothelial cells. Biochem. Biophys. Res. Commun. 249: 683-686
35. Simzar S., Ellyin R., Shau H. and Sarafian T. A. (2000) Contrasting antioxidant and cytotoxic effects of peroxiredoxin I and II in PC12 and NIH3T3 cells. Neurochem. Res. 25: 1613-1621
36. Park S.-H., Chung Y. M., Lee Y.-S., Kim H. J., Kim J. S., Chae H. Z. et al. (2000) Antisense of human peroxiredoxin II enhances radiation-induced cell death. Clin. Cancer Res. 6: 4915-4920
37. Parkes T. L., Elia A. J., Dickinson D., Hilliker A. J., Phillips J. P. and Boulianne G. L. (1998) Extension of Drosophila lifespan by overexpression of human SOD1 in motorneurons. Nat. Genet. 19: 171-174
38. Haan J. de, Newman J. D. and Kola I. (1992) Cu/Zn superoxide dismutase mRaNA and enzyme activity, and susceptibility to lipid peroxidation, increases with aging in murine brains. Brain Res. Mol. Brain Res. 13: 179-187
39. Haan J. de, Cristiano F., Iannello R., Bladier C., Kelner M. J. and Kola I. (1996) Elevation in the ratio of Cu/Zn-superoxide dismutase to glutathione peroxidase activity induces features of cellular senescence and this effect is mediated by hydrogen peroxide. Hum. Mol. Genet. 5: 283-292.
40. Lee M., Hyun D.-H., Halliwell B. and Jenner P. (2001) Effect of overexpression of wild-type and mutant Cu/Zn-superoxide dismutases on oxidative stress and cell death induced by hydrogen peroxide, 4-hydroxynonenal or serum deprivation: potentiation of injury by ALS-related mutant superoxide dismutases and protection by Bcl-2. J. Neurochem 78: 209-220.
41. Sawa A. (1999) Neuronal cell death in Down's syndrome. J. Neural Transm. Suppl. 57: 87-98.